DDX25 inhibitors, often referred to as compounds or molecules falling within the class of small-molecule inhibitors, are a group of chemical entities designed to target and modulate the activity of DDX25, a member of the DEAD-box RNA helicase family. These inhibitors have gained prominence in the field of molecular biology and cellular research due to their ability to selectively interfere with the biological functions of DDX25, a pivotal player in RNA metabolism. DDX25 itself is an RNA helicase enzyme with a critical role in unwinding RNA duplexes, facilitating RNA-protein interactions, and participating in various aspects of RNA processing and maturation. To develop DDX25 inhibitors, researchers have focused on designing compounds that can either directly bind to DDX25 or indirectly affect its function by disrupting cellular processes in which DDX25 is involved.
Direct DDX25 inhibitors are typically small molecules that have been meticulously engineered to interact with specific regions of the DDX25 protein, primarily targeting its ATP-binding site. By binding to this site, these inhibitors obstruct the ATPase activity of DDX25, which is crucial for its RNA unwinding capabilities. Consequently, the disruption of ATP hydrolysis impedes the RNA helicase function of DDX25, leading to a halt in the unwinding of RNA molecules and subsequent interference with processes such as RNA splicing, translation initiation, and ribosomal RNA processing. Indirect DDX25 inhibitors, on the other hand, may not directly bind to DDX25 but instead affect its activity by altering related cellular pathways. For instance, some compounds modulate RNA splicing or ribonucleotide synthesis, indirectly influencing DDX25-mediated processes by creating cellular conditions that are unfavorable for its normal function. This dual approach of directly targeting DDX25 or indirectly impacting its function has provided researchers with valuable tools to dissect the intricate roles of DDX25 in RNA metabolism and unravel the molecular intricacies of these processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triapine | 200933-27-3 | sc-475303 | 10 mg | $300.00 | ||
Triapine is a ribonucleotide reductase inhibitor that indirectly affects DDX25 activity by reducing the availability of deoxyribonucleotides required for RNA synthesis and processing. It can interfere with RNA metabolism by depleting the cellular pool of ribonucleotides. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
CX-5461 is a selective RNA polymerase I inhibitor that indirectly impacts DDX25 by disrupting the synthesis of ribosomal RNA (rRNA). DDX25 is involved in rRNA processing, so inhibiting rRNA production can hinder DDX25-mediated functions. | ||||||
CCG 203971 | 1443437-74-8 | sc-507360 | 10 mg | $89.00 | ||
CCG-203971 is a chemical compound that interferes with RNA helicase activity. It targets DDX25 by binding to its ATPase domain, preventing ATP hydrolysis, and inhibiting RNA unwinding and processing functions. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Pladienolide B is a spliceosome inhibitor that indirectly affects DDX25 by interfering with the splicing of specific mRNA targets. It can lead to the accumulation of unprocessed RNA species and potentially disrupt DDX25-mediated RNA processing. | ||||||
YM 155 | 781661-94-7 | sc-364661 sc-364661A | 5 mg 25 mg | $132.00 $507.00 | 3 | |
YM155 is a survivin inhibitor that indirectly influences DDX25 by modulating the expression of survivin, an anti-apoptotic protein. Changes in survivin levels can impact the apoptotic pathways that DDX25 participates in. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Spliceostatin A is a spliceosome inhibitor that indirectly affects DDX25 by interfering with the splicing of specific mRNA precursors. Changes in splicing patterns can impact DDX25's involvement in RNA processing. | ||||||